Amy Fisher King LCSW
Counselor/Therapist | Mental Health
147 SW SHEVLIN HIXON DR STE 104 BEND OR, 97702About
Amy King is an Addiction Medicine Physician in BEND, OR. Amy evaluates patients using many different procedures, in order to determine what treatments must be carried out in order to properly assess their symptoms. Addiction Medicine Physicians provide medical care in addition to consultation for each patient and their families.
Provider Details
Amy Fisher King LCSW's Practice location
BEND, OR 97702Get Direction
Amy Fisher King LCSW's reviews
Write ReviewRecommended Articles
- Helping a Child with Cystic Fibrosis Find Hope
Cystic fibrosis is a serious and debilitating illness that is lifelong, affecting people often from infancy. What some people may not realize is how difficult it may be for children to understand what is happening to their body.Most small children with the disease have gone through more difficult...
- What Causes Asthma?
Asthma refers to the chronic inflammatory disease of the respiratory system. The causes for asthma differ depending on the individual. During an asthma attack, the airways become narrow, inflamed, and begin to fill with mucus. This makes breathing a difficult task, and leads to coughing and...
- Why Is Taurine Used in Energy Drinks?
TaurineAmino acids are used to build proteins in the body. Taurine is classified as a conditional amino acid, which is not used to build proteins in the body. It is found throughout the body, but it is mostly concentrated in the brain, heart, eyes, and muscles. Taurine is produced in the body but...
- How to Know Your Child is Hyperactive
HyperactivityBetween the age group of 3-12 years, children are active and the syndrome is usually not recognized by parents because they are only thought to be always excited. Usually, the symptoms of a hyperactive child are not easily recognized by parents, according to several reports and...
- Living in the Spotlight with Crohn's Disease
Natalie Hayden is 34, and a former TV news anchor. When she was diagnosed with Crohn's disease, and it changed her life. She endured multiple hospitalizations, was taking too many medications to count, and had seemingly constant flare ups. In 2015, she went in for her first surgery.Throughout her...
- FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis
On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...